Calculate NLR from CBC results with context-specific reference thresholds across general, infectious, cardiovascular, and oncology settings. Includes PLR, LMR, and SII.
The neutrophil-to-lymphocyte ratio (NLR) is a simple, inexpensive marker of systemic inflammation derived from the routine complete blood count (CBC). Calculated by dividing the absolute neutrophil count by the absolute lymphocyte count, NLR reflects the balance between innate immune activation (neutrophils) and adaptive immune regulation (lymphocytes).
Over the past decade, NLR has been widely studied across oncology, cardiology, infectious disease, and general acute-care settings. Higher values are often associated with heavier inflammatory stress, but the meaning depends heavily on context, comorbidities, medications, and the rest of the CBC. Thresholds reported in one population do not automatically translate into a stand-alone diagnosis, triage rule, or prognosis tool in another.
This calculator computes NLR from either absolute counts or WBC differentials, applies context-specific reference cutoffs, provides population percentile estimates, and optionally calculates related inflammatory ratios including the platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and systemic immune-inflammation index (SII).
NLR is useful when you need a quick inflammation signal from a CBC that is already being drawn. It helps frame the result as part of a larger pattern, whether the question is infection, oncology context, cardiovascular risk, or critical illness, instead of treating the ratio as a standalone diagnosis.
NLR = Absolute Neutrophil Count ÷ Absolute Lymphocyte Count. If using differentials: ANC = WBC × (Neutrophil% / 100), ALC = WBC × (Lymphocyte% / 100). Related ratios: PLR = Platelets ÷ ALC; LMR = ALC ÷ Monocytes; SII = ANC × Platelets ÷ ALC.
Result: NLR 2.57 — Normal range; PLR 119.0; Population 54th percentile
An NLR of 2.57 falls within the normal range (1.0–3.0) for the general population, sitting at approximately the 54th percentile. The PLR of 119 is also within normal limits (<180). No evidence of significant systemic inflammation from these markers.
In acute-care settings, NLR is often reviewed because a CBC with differential is available early and cheaply. Higher values can support the impression that a patient is under greater inflammatory stress, but the ratio is nonspecific and should not be turned into a stand-alone workflow rule. The most useful role for NLR is as one contextual marker beside vital signs, symptoms, imaging, chemistry results, and the rest of the CBC.
The link between inflammation and atherosclerosis is well-established, and NLR has been studied as one marker within that relationship. In acute coronary syndrome, higher admission NLR values have been associated with worse short-term outcomes and more complex inflammatory burden. In stable coronary artery disease, NLR has also been associated with future events. Those associations are useful background context, but they do not replace standard cardiovascular risk tools, biomarkers, or imaging.
Despite its utility, NLR has important limitations. It is nonspecific — any cause of stress, inflammation, or immune activation alters the ratio. Physical exercise, psychological stress, and even time of day (diurnal cortisol variation) affect NLR. Medications, particularly corticosteroids, can render NLR uninterpretable. NLR does not distinguish between different types of infection, inflammation, or malignancy. Optimal cutoff values vary by population, clinical context, and study methodology. NLR should always be interpreted alongside the complete clinical picture, not in isolation.
Last updated:
This worksheet divides the entered absolute neutrophil count by the absolute lymphocyte count, then applies context-specific reference bands and related inflammatory ratios. It is a contextual CBC-based marker, not a diagnosis or a stand-alone severity score.
In healthy adults, NLR typically ranges from 1.0 to 3.0, with a median around 1.65–2.15 depending on the population studied. Values below 1.0 may indicate relative neutropenia or lymphocytosis (seen in viral infections, some medications, or autoimmune conditions). Values above 3.0 suggest some degree of systemic inflammation. The "normal" range shifts with age and sex — older adults and males tend to have slightly higher NLR.
NLR is one of the most studied inflammatory markers in oncology, and higher pre-treatment values have often been associated with worse outcomes across many solid tumors. Even so, it is best treated as background inflammatory context rather than as a stand-alone prognostic tool.
NLR, CRP, and procalcitonin reflect different parts of the inflammatory response. NLR is easy to obtain from a CBC, but it is less specific than dedicated infection markers and works best as context rather than as a replacement for CRP, procalcitonin, cultures, or the rest of the assessment.
SII = Neutrophils × Platelets ÷ Lymphocytes. It integrates three immune/inflammatory cell types into a single index. By incorporating platelets, SII can provide broader inflammatory context than NLR alone, but it should still be read as a reference marker rather than as a stand-alone decision tool.
Yes, many medications significantly alter NLR. Corticosteroids cause neutrophilia and lymphopenia, dramatically increasing NLR — even a single dose can double NLR within hours. Chemotherapy can cause neutropenia, lowering NLR. Beta-blockers may slightly lower NLR through stress hormone modulation. Immunotherapy (checkpoint inhibitors) can cause lymphocytosis. Always consider the medication list when interpreting NLR, especially recent corticosteroid exposure.
NLR was widely studied during the COVID-19 pandemic, but this page should not be used as a stand-alone respiratory assessment tool. A higher NLR can add inflammatory context, yet the result still needs to be read alongside symptoms, oxygenation, imaging, and the rest of the clinical picture.